Ahmed M. Bayoumi

MD, MSc

Scientist

Biography

Dr. Ahmed Bayoumi is a Scientist at MAP Centre for Urban Health Solutions at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, where he is also a general internist and Human Immunodeficiency Virus (HIV) physician. He holds the Fondation Baxter and Alma Ricard Chair in Inner City Health at St. Michael’s Hospital and the University of Toronto and is a Professor in the Department of Medicine and in the Institute of Health Policy, Management and Evaluation at the University of Toronto. He is a Senior Adjunct Scientist at ICES. He has extensive experience in translating research to policy (member of the Canadian Drug Expert Committee, past Scientific Director of Converge3, past president of the international Society for Medical Decision Making, and past Director of Clinical Epidemiology and Health Care Research at the University of Toronto). He has co-led large multi-method studies, including the highly impactful Toronto and Ottawa Supervised Consumption Assessment (TOSCA) and the Marginalization and COVID-19 (MARCO) studies. His research interests include the delivery of health services, particularly to people who use drugs, people living with HIV, and other marginalized populations. He is a member of HMRAC (the Homelessness, Mortality, Research and Advocacy Coalition), an academic – community collaboration that meets regularly to discuss how research can address issues related to homelessness.

Recent Publications

  1. Talaat, H, Bashayan, S, J N Raymakers, A, Bayoumi, AM, Papatheodorou, S, Sediqzadah, S et al.. Health-related quality of life measures in incarcerated populations: protocol for a scoping review. BMJ Open. 2022;12 (4):e052800. doi: 10.1136/bmjopen-2021-052800. PubMed PMID:35470181 PubMed Central PMC9039373.
  2. Paul, LA, Li, Y, Leece, P, Gomes, T, Bayoumi, AM, Herring, J et al.. Identifying the changing age distribution of opioid-related mortality with high-frequency data. PLoS One. 2022;17 (4):e0265509. doi: 10.1371/journal.pone.0265509. PubMed PMID:35442953 PubMed Central PMC9020746.
  3. Raafat, M, Kamel, AA, Shehata, AH, Ahmed, AF, Bayoumi, AMA, Moussa, RA et al.. Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2. Pharmaceuticals (Basel). 2022;15 (2):. doi: 10.3390/ph15020130. PubMed PMID:35215244 PubMed Central PMC8880638.
  4. Kendall, CE, Boucher, LM, Donelle, J, Martin, A, Marshall, Z, Boyd, R et al.. Cohort study of team-based care among marginalized people who use drugs in Ottawa. Can Fam Physician. 2022;68 (2):117-127. doi: 10.46747/cfp.6802117. PubMed PMID:35177504 .
  5. Young, S, Kolla, G, McCormack, D, Campbell, T, Leece, P, Strike, C et al.. Characterizing safer supply prescribing of immediate release hydromorphone for individuals with opioid use disorder across Ontario, Canada. Int J Drug Policy. 2022;102 :103601. doi: 10.1016/j.drugpo.2022.103601. PubMed PMID:35124413 .
  6. O'Brien, KK, Bayoumi, AM, Chan Carusone, S, Davis, AM, Aubry, R, Avery, L et al.. Disability and self-care living strategies among adults living with HIV during the COVID-19 pandemic. AIDS Res Ther. 2021;18 (1):87. doi: 10.1186/s12981-021-00413-4. PubMed PMID:34798881 PubMed Central PMC8604195.
  7. Ibrahim, YF, Refaie, MM, Kamel, MY, Ahmed, SM, Moussa, RA, Bayoumi, AM et al.. Molecular mechanisms underlying the effect of diacerein on trichloroacetic acid-induced hepatic pre-neoplastic lesions in rats. Hum Exp Toxicol. 2021;40 (12_suppl):S788-S803. doi: 10.1177/09603271211056331. PubMed PMID:34794354 .
  8. Tan, DHS, Rana, J, Tengra, Z, Hart, TA, Wilton, J, Bayoumi, AM et al.. Preferences regarding emerging HIV prevention technologies among Toronto men who have sex with men: a discrete choice experiment. Sci Rep. 2021;11 (1):22252. doi: 10.1038/s41598-021-01634-3. PubMed PMID:34782691 PubMed Central PMC8592986.
  9. Mohamed, EI, El-Ghnam, SM, Bayoumi, AM, Abdel-Mageed, SM, Ghareeb, DA, Ross, B et al.. Electronic nose versus quadrupole mass spectrometry for identifying viral hepatitis C patients. J Viral Hepat. 2022;29 (2):147-155. doi: 10.1111/jvh.13630. PubMed PMID:34773341 .
  10. Gomes, T, Kitchen, SA, Tailor, L, Men, S, Murray, R, Bayoumi, AM et al.. Trends in Hospitalizations for Serious Infections Among People With Opioid Use Disorder in Ontario, Canada. J Addict Med. 2021; :. doi: 10.1097/ADM.0000000000000928. PubMed PMID:34711742 .
Search PubMed

Affiliations & Other Activities

  • Scientist, MAP Centre for Urban Health Solutions, St. Michael’s Hospital
  • Professor, Department of Medicine, University of Toronto
  • Professor, Institute of Health Policy, Management and Evaluation, University of Toronto
X